Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

MAML2 anticorps

Cet anticorps Souris Monoclonal détecte spécifiquement MAML2 dans WB, IF, FACS, ISt et IHC (f). Il présente une réactivité envers Humain.
N° du produit ABIN6937802

Aperçu rapide pour MAML2 anticorps (ABIN6937802)

Antigène

Voir toutes MAML2 Anticorps
MAML2 (Mastermind-Like 2 (MAML2))

Reactivité

  • 27
  • 5
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
Humain

Hôte

  • 17
  • 11
Souris

Clonalité

  • 17
  • 11
Monoclonal

Conjugué

  • 17
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp MAML2 est non-conjugé

Application

  • 22
  • 13
  • 10
  • 8
  • 8
  • 7
  • 4
  • 2
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB), Immunofluorescence (IF), Flow Cytometry (FACS), Immunostaining (ISt), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))

Clone

MAML2-1302
  • Specificité

    MAML2 (mastermind-like protein 2), also known as MAM2, MAM3 or MLLMAML2, is a nuclear speckle protein that acts as a transcriptional co-activator for Notch receptors. The Notch signaling pathway influences cell fate by regulating the ability of precursor cells to properly respond to developmental signals. MAML2 is a member of the mastermind-like family of proteins that are human homologs of the Drosophila melanogaster mastermind protein. Through its N-terminal region, MAML2 interacts with the ankyrin repeats of the Notch proteins Notch 1, Notch 2, Notch 3 and Notch 4. This interaction leads to formation of a DNA-binding complex with the Notch proteins and RBP-J a complex that can then induce HES1 gene expression. While the N-terminal domain of MAML2 is essential for proper Notch binding, the C-terminal domain of MAML2 is essential for transcriptional activation. A chromosomal aberration involving the gene encoding MAML2 is implicated in mucoepidermoid carcinomas, clear cell hidradenomas and benign Warthin tumors.

    Réactivité croisée (Details)

    Human.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogène

    Recombinant human MAML2 fragment

    Isotype

    IgG2a kappa
  • Indications d'application

    Known_Application: Flow Cytometry (1-2 μg/million cells), Immunofluorescence (1-2 μg/mL), Western Blot (1-2 μg/mL), Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT)(Staining of formalin-fixed tissues is enhanced by heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0 for 45 min at 95°C followed by cooling at RT for 20 minutes)Optimal dilution for a specific application should be determined.

    Positive_Control: MCF-7 cells. Pancreas or Placenta. Bladder or Colon Carcinoma.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Agent conservateur

    Azide free

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Date de péremption

    24 months
  • Antigène

    MAML2 (Mastermind-Like 2 (MAML2))

    Autre désignation

    MAML2

    Sujet

    Mam-2, MAML2, Mastermind-like protein 2,MAML2 (Mastermind Like Transcriptional Coactivator 2)
    Cellular localisation: Cytoplasmic

    Poids moléculaire

    125kDa

    ID gène

    84441, 428214

    UniProt

    Q8IZL2
Vous êtes ici:
Chat with us!